Nov 14, 2019
Highlights Cancer being a life-threatening condition with unmet medical need, many cancer drugs are approved through an accelerated approval pathway introduced by US FDA in 1992 based on surrogate endpoints. Studies have found that only a small % of FDA/EMA approved...
